NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-153-2023-0-US-01 Rebalancing the Immune System Through Depletion of Myeloid-Biased Hematopoietic Stem Cells US 63/422,765 Expired
NIAID E-001-2024-0-US-03 Viral Strain Serology Assays US 63/382,391 Expired
NIAID E-149-2022-0-US-01 NOVEL ANTIBODIES FOR HIV AND METHODS OF MAKING AND USING SAME US 63/422,250 Expired
NIAID E-197-2023-0-US-03 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US 63/381,850 Expired
NIAID E-197-2023-1-US-02 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US 63/381,842 Expired
NCI E-150-2017-2-HK-01 Diagnostic Methods For T Cell Therapy HK CN 42022062958.8 Pending
NCI E-213-2022-0-US-01 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST BRAF WITH V600E MUTATION US 63/381,587 Expired
NCI E-206-2022-0-US-01 T CELL RECEPTORS TARGETING MUTATED CDKN2A US 63/381,591 Expired
NIDCR E-150-2019-0-US-03 Application Of AAV44.9 Vector In Gene Therapy For The Inner Ear US National Stage 17/922,300 Pending
NCATS E-004-2016-0-CN-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF CN DIV 202211334125.9 Pending
NCI E-141-2008-0-JP-36 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof JP DIV 2022-172896 Expired
NCATS E-043-2017-3-US-01 Pharmaceutical Compositions With Antiflaviviral Activity US CON 18/050,177 Pending
NICHD E-200-2021-0-PCT-02 USE OF CARBOXYPEPTIDASE E/NEUROTROPHIC FACTOR-ALPHA1 TO TREAT NEURODEGENERATIVE DISEASE PCT PCT PCT/US2022/078713 Expired
NIAID E-002-2023-0-US-01 VESICULAR STOMATITIS VIRUS (VSV)-BASED VACCINE AGAINST SUDAN VIRUS US 63/419,637 Expired
NCI E-204-2021-0-PCT-02 SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN PCT PCT PCT/US2022/078632 Expired
NCI E-104-2013-0-US-06 ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US CON 18/049,470 Abandoned
NCI E-234-2014-1-HK-02 METHODS 0F PRODUCTION OF AUTOLOGOUS T CELLS FOR TREATMENT OF B-CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF HK CN 42022062626.1 Pending
NCI E-135-2019-0-HK-17 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 HK EP 62022062662.1 Pending
NIAID E-097-2020-0-KR-09 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE KR National Stage 10-2022-7037236 Pending
NIAID E-025-2023-0-US-01 Combination Treatment For Treating Cancer US 63/380,929 Expired
NIAID E-174-2023-0-US-01 Self-Assembling Nanoparticles US 63/380,931 Expired
NIAID E-297-2016-2-AU-11 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES AU DIV 2022256195 Issued
NICHD E-072-2017-0-JP-08 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE JP DIV 2022-169032 Abandoned
NCI E-192-2023-0-PC-01 Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis PCT PCT PCT/EP2022/079286 Expired
NIDDK E-108-2020-0-EP-03 Thyclotides EP National Stage 21723830.2 Pending
NCI E-192-2023-0-TW-01 Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis TW ORD 111139905 Pending
NCI E-244-2015-0-AU-21 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use AU DIV 2022256143 Issued
OD E-120-2021-0-PCT-02 PREDICTION OF TRANSFORMATIVE BREAKTHROUGHS IN RESEARCH PCT PCT PCT/US2022/047099 Expired
NCI E-102-2020-0-EP-06 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY EP National Stage 21718376.3 Pending
NIA E-197-2022-0-US-01 ISLET AMYLOID POLYPEPTIDE ISOFORMS AND PEPTIDES AND METHODS OF USE US 63/417,582 Expired
NIAID E-131-2019-0-US-06 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE US National Stage 17/919,733 Pending
NCI E-102-2020-0-KR-08 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY KR National Stage 10-2022-7036226 Pending
NCI E-061-2020-0-KR-08 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY KR National Stage 10-2022-7036214 Pending
NIDDK E-108-2020-0-US-04 Thyclotides US National Stage 17/918,725 Pending
NIAID E-080-2013-0-EP-11 Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization EP DIV 22201434.2 Pending
NCI E-003-2022-0-PCT-02 AUTOMATIC SYSTEM AND METHOD FOR TISSUE SECTIONING, STAINING, AND SCANNING PCT PCT PCT/US2022/046406 Expired
NCI E-216-2022-0-US-01 Deep Characterization of Cancer Drug Mechanism of Action by Integrating Large-Scale Genetic and Drug Screens US 63/415,560 Expired
NCI E-055-2017-0-CN-13 Combination Therapy of Immunotoxin and Checkpoint Inhibitor CN DIV 202211240353.X Abandoned
NCI E-061-2020-0-EP-06 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY EP National Stage 21718712.9 Pending
NCI E-075-2020-0-EP-05 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES EP National Stage 21715394.9 Pending
NIAID E-228-2016-1-AU-15 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof AU DIV 2022246465 Issued
NIBIB E-168-2021-2-PCT-01 Systems and Methods for Three-Dimensional Structured Illumination Microscopy With Isotropic Spatial
Resolution 		PCT PCT COMB PCT/US2022/077763 Expired
NIA E-207-2021-0-PCT-02 COMPOUNDS AND MOLECULAR TARGETS FOR TREATING AND/OR PREVENTING ALZHEIMER'S DISEASE PCT PCT PCT/US2022/046018 Expired
NCI E-040-2012-0-US-72 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/938,535 11827889 Issued PDF
NCI E-040-2012-0-US-71 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/938,529 11773396 Issued PDF
NIAID E-160-2021-0-PCT-02 AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTERACTION OF LILRBS WITH MHC-1 PCT PCT PCT/US2022/077634 Expired
NIAID E-052-2021-0-KR-01 Engineered Influenza Neuraminidase Antigens KR National Stage 10-2022-7034599 Pending
NCATS E-001-2023-1-US-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/378,306 Expired
NCATS E-001-2023-0-US-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/378,300 Expired
NIAID E-178-2014-2-US-11 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE US CON 17/937,719 12145968 Issued PDF